http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104983706-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 |
| filingDate | 2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104983706-B |
| titleOfInvention | Sodium Prasterone Sulfate sustained release tablets and its preparation process |
| abstract | The present invention proposes Sodium Prasterone Sulfate sustained release tablets and its preparation process, wherein Sodium Prasterone Sulfate sustained release tablets include：The Sodium Prasterone Sulfate of 10-90 weight %；The framework material of 5-75 weight %；The filler of 0.1-80 weight %；And the lubricant of 0.1-5 weight %.The above-mentioned Sodium Prasterone Sulfate sustained release tablets of the embodiment of the present invention only need to take a drug for one day, and patient complies with；The blood concentration of stable state can be provided, maintain Finite Concentration to improve the safety of drug to reduce the toxic side effect of drug for a long time. |
| priorityDate | 2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.